DocGo Inc. DCGO
Nasdaq · XNAS · stock · Services-Health Services · website · IPO 2020-10-15
Chart by TradingView
4/9
Piotroski F — financial health
-4.26
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $322.2M | $616.6M | $624.3M | $440.5M | $318.7M |
| Operating income | -$178.0M | $28.7M | $15.1M | $21.8M | $15.4M |
| Net income | -$182.4M | $20.0M | $6.9M | $34.6M | $23.7M |
| Operating cash flow | $34.5M | $70.1M | -$64.5M | $28.9M | -$1.9M |
| Free cash flow | $29.9M | $66.5M | -$71.8M | $25.7M | -$6.8M |
| Total assets | $217.1M | $455.6M | $490.5M | $393.3M | $309.6M |
| Total liabilities | $91.2M | $140.4M | $185.3M | $114.4M | $82.5M |
| Shareholders' equity | $125.9M | $315.2M | $305.2M | $278.9M | $227.1M |
| Ratios | |||||
| Operating margin | -55.3% | 4.7% | 2.4% | 5.0% | 4.8% |
| Net margin | -56.6% | 3.2% | 1.1% | 7.9% | 7.4% |
| FCF margin | 9.3% | 10.8% | -11.5% | 5.8% | -2.1% |
| Return on assets | -84.0% | 4.4% | 1.4% | 8.8% | 7.7% |
| Return on equity | -144.9% | 6.3% | 2.2% | 12.4% | 10.5% |
| Debt / equity | 0.00× | 0.00× | 0.00× | — | — |
| Current ratio | 2.26 | 2.50 | 1.99 | 2.71 | 4.42 |
| Revenue growth | -47.7% | -1.2% | 41.7% | 38.2% | 238.7% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,510,361 | $950,168 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -4.26 (distress)
- Working capital / assets 0.391
- Retained earnings / assets -0.847
- EBIT / assets -0.82
- Equity / liabilities 1.38
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001822359 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.